baber/WOPTO huggingface dataset:
Patent MX-2019009487-A (MX)
Title: Sorbent and method of making.
Inventor: Rebecca Distefano
IPC: B01J20/20
Filed: 2018-02-12
Abstract: Sorbents are disclosed which exhibit less inherent leaching of arsenic and antimony than what is achieved by conventional sorbents. The inventive sorbents are formed by a process which includes the steps of contacting the porous sorbent particulate with a solution of a metal oxide or metal hydroxide, or a metal oxide or metal hydroxide precursor, and depositing metal oxides and hydroxides within the pores of the porous sorbent particulate. Purification of water is also described.
Patent MX-2019010024-A (MX)
Title: Method for manufacturing steel fuel-pressure-feeding pipe.
Inventor: TAKETO IKENOYA
IPC: F02M55/02
Filed: 2017-12-27
Abstract: Provided is a method for manufacturing a high-quality steel fuel-pressure-feeding pipe having high resistance to corrosive fuel. This method is characterized in that steel pipe material is sorted into pipe material in which initial flaws (tiny cracks, wrinkle flaws, weld defects, etc.) in the inner peripheral surface of the pipe material exceeds a preset threshold value and pipe material in which the threshold value is not exceeded, and after initial flaws in the inner peripheral surfaces of the pipe material not exceeding the threshold value are removed by mechanical cutting, a surface treatment of Ni plating or the like is performed on the inner peripheral surfaces of this pipe material.
Patent MX-2019012058-A (MX)
Title: Assay to measure the potency of receptor-ligand interactions in nanomedicines.
Inventor: PEDRO SANTAMARIA
IPC: G01N33/00
Filed: 2018-04-05
Abstract: Described herein, is an isolated cell comprising a recombinant T cell receptor (TCR) and a TCR- pathway-dependent reporter, wherein the recombinant T cell receptor is specific for a disease- relevant antigen bound to an MHC molecule. Also described are methods of use for the isolated cell as an assay to determine the function or potency of a peptide-major histocompatibility complex (pMHC) coupled to a nanoparticle (pMHC-NP) that can be used as a medicine for treating an autoimmune disease or cancer.
Patent MX-2019013466-A (MX)
Title: Dosing device for a supply of liquid, comprising a neck.
Inventor: HERBERT WOHLGENANNT
IPC: G01F11/06
Filed: 2018-05-18
Abstract: The dosing device is intended for a neck for pouring defined amounts from a container or hose. The device consists of a spout attachment that can be screwed or pushed onto the neck and that optionally can be sealed by a separate lid, said attachment comprising a dosing control chamber (14) having a variable volume. As a characterizing feature, this chamber fills up from empty during pouring. Said chamber is formed by an area between the control chamber limiter and the interior of a dosing plunger (10) and fills up with liquid during the pouring of an amount, while liquid flows downward at (D1) past the dosing plunger (10) to the spout (3). Ultimately, when fully depressed downwards the dosing plunger (10) closes the spout (3) when the control chamber (14) is full. The dose amounts to be poured out can be adjusted by limiting the path of the dosing plunger (10) on its side facing the container or hose. The control chamber limiter is variably displaceable, axially relative to the dosing device, into the neck equipped with said device and can be permanently secured in any position.
Patent MX-2019014666-A (MX)
Title: Pharmaceutical composition comprising c-met antibody-drug conjugate and use thereof.
Inventor: XUN LIU
IPC: A61K47/68
Filed: 2018-06-05
Abstract: A stable c-Met antibody-drug conjugate (c-Met ADC) formulation and use thereof in medicine. Said formulation comprises c-Met ADC, a buffer, and can also comprise at least one stabilizer, and optionally a surfactant. The c-Met ADC formulation of the present invention can effectively inhibit the aggregation and isomerization of antibodies, and prevent the degradation of an antibody product therein, being a stable injectable pharmaceutical formulation.
Patent MX-2020001978-A (MX)
Title: Durable pest-repelling formulations.
Inventor: YARKONI YAIR
IPC: A01N25/02
Filed: 2018-08-20
Abstract: Formulations usable in repelling pests from objects are provided. The formulations contain a tacky polymeric composition and can be aqueous formulations and/or formulation that are devoid of an organic solvent. The formulations exhibit exceptional durability when applied to objects such as plants.
Patent MX-2020007177-A (MX)
Title: Crystals.
Inventor: FUJIWARA TOSHIO
IPC: C07D401/14
Filed: 2018-09-27
Abstract: The main purpose of the present invention is to provide novel crystals of (S)-N<sup>2</sup>-[1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyra zol-4-yl)-N<sup>6</sup>-(pyrazin-2-yl)pyridine-2,6-diamine maleate (hereinafter "compound A"). A type I crystal of compound A, exhibiting diffraction peaks at diffraction angles (2Î¸) of 6.9 degrees, 9.4 degrees, 12.5 degrees, 15.1 degrees, 16.4 degrees, 18.3 degrees, 19.0 degrees, 24.9 degrees, 25.4 degrees, 27.3 degrees, and 27.7 degrees in the powder x-ray diffraction spectrum obtained using CuKÎ± radiation (Î» = 1.54 Ã ). A type II crystal of compound A, exhibiting diffraction peaks at diffraction angles (2Î¸) of 6.9 degrees, 9.2 degrees, 12.4 degrees, 14.8 degrees, 16.5 degrees, 18.1 degrees, 18.5 degrees, 19.8 degrees, 23.6 degrees, 24.9 degrees, and 27.7 degrees in the powder x-ray diffraction spectrum obtained using CuKÎ± radiation (Î» = 1.54 Ã ).
Patent MX-2020008509-A (MX)
Title: Method for the isomerization of a 3-(z)-unsaturated carboxylic acid to the 3-(e)-isomer.
Inventor: SCHELWIES MATHIAS
IPC: C07C51/353
Filed: 2019-02-13
Abstract: The present invention relates to a method for isomerizing a 3-(Z)-unsaturated carboxylic acid of the formula l-Z or a salt thereof, wherein R<sup>2</sup> is C<sub>1</sub>-C<sub>24</sub>-alkyl, C<sub>2</sub>-C<sub>24</sub>-alkenylhaving 1, 2, 3 or more than 3 C-C double bonds, unsubstituted or substituted C<sub>5</sub>-C<sub>12</sub>-cycloalkyl, or unsubstituted or substituted aryl; R<sup>1</sup> is hydrogen or has one of the definitions specified for R<sup>2</sup>; with the proviso that R<sup>2</sup> has a higher priority than R<sup>1</sup> in accordance with lUPAC; to give a 3-(<i>E</i>)-unsaturated carboxylic acid of the formula I-E or a salt thereof, wherein the isomerization of the compound of the formula l-Z is effected in the presence of an anhydride of an organic acid and a base or in the presence of a ketene of formula CR<sup>11</sup>R<sup>12</sup>C(0), wherein R<sup>11</sup> and R<sup>12</sup> are as defined in the claims and in the specification and a base. In particular, the present invention relates to a method for preparing compositions with increased content of (3<i>E</i>, 7<i>E</i>)-homofarnesylic acid starting from compositions comprising (3<i>Z</i>,7<i>E</i>)- and (3<i>E</i>, 7<i>E</i>)-homofarnesylic acid.
Patent MX-2020011348-A (MX)
Title: Contact center system and methods for handling voice and data teleservices through mobile devices.
Inventor: ALONSO Y CALOCA AURELIO LUIS MIGUEL
IPC: H04M1/72406
Filed: 2019-04-29
Abstract: A contact center system and related methods for handling teleservices in voice and data through a plurality of mobile devices such as smartphones is provided. The contact center system is characterized by a very wide functional platform for contact center fully integrated in a single system, with maximum elasticity to increase or decrease capacities based on the characteristics of the cloud, and capable to deliver via an agent mobile platform all the functionality of a fixed-up workstation into a smartphone. The contact center system according to the embodiments is capable to route a call from a customer's device, using a local telecommunications network, to the contact center system, which transforms it into a digital call; the call is assigned to an agent using a mobile platform.
Patent MX-2020013081-A (MX)
Title: A waste treatment system.
Inventor: CUMMINS IAN GEOFFREY
IPC: C02F1/32
Filed: 2019-05-31
Abstract: A waste treatment system including at least one treatment chamber through which a fluid to be treated is moved in a fluid flow, the or each treatment chamber including at least one of a number of ultraviolet light sources, and at least one dispersion assembly located at a base of the treatment chamber to disperse at least one sterilizing agent supplied to the treatment chamber in a counter flow direction to the fluid flow.
Patent MX-2021000889-A (MX)
Title: ANTIBODY DIRECTED AGAINST S. <i>AUREUS</i> CLUMPING FACTOR A (CLFA).
Inventor: SELLMAN BRET
IPC: C07K16/12
Filed: 2019-07-24
Abstract: The present disclosure is directed to a monoclonal antibody, or antigen-binding fragment thereof, that specifically binds to a <i>Staphylococcus</i> <i>aureus</i> clumping factor A protein (ClfA), as well as compositions comprising the monoclonal antibody. The disclosure also is directed to methods of treating a <i>Staphylococcus</i> <i>aureus</i> infection by administering the anti-ClfA monoclonal antibody alone, or in combination with a monoclonal antibody that specifically binds to S. <i>aureus</i> alpha toxin (AT) protein to a subject. Bispecific monoclonal antibodies that specifically bind to both ClfA and AT and methods of using the same also are provided.
Patent MX-2021004914-A (MX)
Title: Soft-nitriding steel, soft-nitrided component, and methods for manufacturing same.
Inventor: NISHIMURA KIMIHIRO
IPC: C21D1/06
Filed: 2019-10-28
Abstract: Provided is a soft-nitriding steel having machinability ensured before a soft-nitriding process. A soft-nitriding steel according to the present invention has a compositional makeup containing, in mass%, not less than 0.02 % but less than 0.15% of C, not more than 0.30% of Si, 1.5-2.5% of Mn, not more than 0.025% of P, not more than 0.06% of S, 0.5-2.0% of Cr, 0.005-0.2% of Mo, 0.02-0.20% of V, 0.003-0.20% of Nb, more than 0.020% but not more than 1.0% of Al, more than 0.0050% but not more than 0.015% of Ti, not more than 0.0200% of N, and 0.0030-0.010% of Sb in ranges satisfying formula (1) or (2), with the remainder being Fe and unavoidable impurities, and has a steel structure wherein: the area percentage of a bainite phase is more than 50%; the prior austenite grain size is not more than 100 Î¼m; Ti deposits having an equivalent circular grain size of not more than 30 nm are dispersed at a rate of not less than 300 pieces/Î¼m<sup>2</sup>; and Sb is segregated on the prior austenite grain boundary.
Patent MX-2021005296-A (MX)
Title: COSMETIC COMPOSITION, METHOD FOR PRODUCING OIL AND/OR BUTTER FROM <i>ASTROCARYUM VULGARE</i>, USE OF THE COSMETIC COMPOSITION AND METHOD OF PRODUCTION OF AND/OR PROTECTION AGAINST DEGRADATION OF HYALURONIC ACID IN THE SKIN.
Inventor: FERRARI CINTIA ROSA
IPC: A61Q19/08
Filed: 2019-06-17
Abstract: The present invention relates to a cosmetic composition comprising oil and/or butter from <i>Astrocaryum vulgare</i>, which can be used for the production of and/or protection against degradation of hyaluronic acid in the skin, to the process of production thereof, and also to related uses and methods.
Patent MX-2021006405-A (MX)
Title: Multi-sport center with cooling and heating system.
Inventor: CHO BYOUNGKOO
IPC: A62C19/00
Filed: 2021-05-31
Abstract: The present invention relates to a multi-sport center and more specifically, a multi-sport center having sectors used for various sport games and a passage separating the sectors, wherein each sector includes courts formed according to court standards of sports whose courts are inter-compatible to each other, and the adjacent courts are inter-compatible, thereby increasing efficiency of a sport center. The center further comprises more than one cooling and heating booth installed at one side of each sector, thereby helping players in each court to take breaks. In addition, the center further comprises cantilevers that is installed on an inner wall at the second to the fourth floor level and that can look down the first floor, wherein a café, a snack bar, a media room, an electronic game room, a go game room, and jogging track, instead of stands, are installed on the cantilevers.
Patent MX-2021012844-A (MX)
Title: Blending virtual environments with situated physical reality.
Inventor: OFEK EYAL
IPC: G06T19/00
Filed: 2020-03-17
Abstract: Various embodiments are provided herein for tracking a user's physical environment, to facilitate on-the-fly blending of a virtual environment with detected aspects of the physical environment. Embodiments can be employed to facilitate virtual roaming by compositing virtual representations of detected physical objects into virtual environments. A computing device coupled to a HMD can select portions of a depth map generated based on the user's physical environment, to generate virtual objects that correspond to the selected portions. The computing device can composite the generated virtual objects into an existing virtual environment, such that the user can traverse the virtual environment while remaining aware of their physical environment. Among other things, the computing device can employ various blending techniques for compositing, and further provide image pass-through techniques for selective viewing of the physical environment while remaining fully-immersed in virtual reality.
Patent MX-2022000852-A (MX)
Title: Cells expressing chimeric antigen receptors and chimeric stimulating receptors and uses thereof.
Inventor: LIU HONG
IPC: A61K35/17
Filed: 2020-07-24
Abstract: Described herein are immune cells comprising: a chimeric antigen receptor (CAR) that comprises (i) an extracellular target-binding domain comprising an antibody moiety; (ii) a transmembrane domain; and (iii) a primary signaling domain, and a chimeric stimulating receptor (CSR) that comprises (i) a ligand-binding module that is capable of binding or interacting with a target ligand; (ii) a transmembrane domain; and (iii) a CD30 costimulatory domain, in which the CSR in the immune cells lacks a functional primary signaling domain. Also provided herein are methods of using the same or compositions thereof for therapeutic treatment of cancers (e.g., hematological cancers or solid tumor cancers).
Patent MX-2022002873-A (MX)
Title: Novel molecules for diagnosis.
Inventor: ADOLFSSON OSKAR
IPC: C07K16/18
Filed: 2020-09-10
Abstract: The present invention relates to novel amyloid-beta (abeta) binding molecules, in particular to abeta antibodies or antigen-binding fragments thereof and/or uses thereof. The provided molecules can also be used for determining a predisposition to amyloid-beta associated diseases, disorders or conditions, monitoring residual disorder of a disease or condition, or predicting the responsiveness of a patient who is suffering from such disease or condition to the treatment with a certain medicament. Thus, the invention relates to novel molecules that can be employed for the diagnosis of diseases, disorders or conditions associated with amyloid-beta. A sandwich immunoassay may be based on capture and detection amyloid-beta binding antibodies or antigen-binding fragments thereof in which one or other of the capture or detection antibody or antigen-binding fragment thereof displays no cross-reactivity to soluble amyloid precursor protein (APP). The other amyloid-beta binding antibody or antigen-binding fragment my display cross- reactivity to soluble amyloid precursor protein (APP) without compromising the specificity of the assay against soluble APP.
Patent MX-2022003810-A (MX)
Title: Vibration noise reduction analysis method and analysis device for automotive panel component.
Inventor: SHIOZAKI TSUYOSHI
IPC: B62D21/00
Filed: 2020-05-07
Abstract: A vibration noise reduction analysis method for an automotive panel component according to the present invention comprises: acquiring a vehicle body mesh model that includes a vibration noise reduction target panel component model and a vibration transmission frame component model and in which an excitation source is set (S1); selecting a specific frequency band for the vibration noise reduction target panel component model (S3); specifying the vibration transmission frame component model that contributes significantly to vibration noise from the vibration noise reduction target panel component model (S5); optimizing the plate thickness for each mesh of the specified vibration transmission frame component model (S7); setting a division area in the specified vibration transmission frame component model, on the basis of the optimized plate thickness for each mesh (S9); optimizing the plate thickness for each division area (S11); and determining the division area and the optimum plate thickness of the vibration transmission frame component model, on the basis of the plate thickness optimized for each division area (S13).
Patent MX-2022005159-A (MX)
Title: Use of biomarkers to predict clinical sensitivity to 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1- oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide.
Inventor: LU GANG
IPC: A61K31/454
Filed: 2020-10-27
Abstract: A method of identifying a subject having cancer who is likely to be responsive to a treatment comprising a compound or predicting the responsiveness of a subject having or suspected of having cancer to a treatment comprising the compound, comprising: providing a sample from the subject; measuring gene expression level of one or more genes in the sample; and identifying the subject as being likely to be responsive to the treatment comprising the compound if the expression level of the gene is different from a reference level, and wherein the gene is a gene involved in mTOR signaling, or the gene is ILF 2 or ILFS.
Patent MX-2022005819-A (MX)
Title: Novel functionalized lactones as modulators of the 5-hydroxytryptamine receptor 7 and their method of use.
Inventor: CANNEY DANIEL J
IPC: A61P25/04
Filed: 2020-11-12
Abstract: Described herein are new, selective modulators of the 5-HT<sub>7</sub>receptor. These selective compounds can be useful for the treatment of CNS and non-CNS indications. Compounds described herein can be selective in targeting 5-HT<sub>7</sub> receptors as compared to other receptors and/or by selective targeting 5-HT<sub>7</sub> receptors expressed in certain tissues or organs, thereby effective selectivity through a particular partitioning profile of the 5-HT<sub>7</sub> modulator.
Patent MX-2022006147-A (MX)
Title: Methods of cancer treatment using anti-ox40 antibodies in combination with anti-pd1 or anti-pdl1 antibodies.
Inventor: LIU YE
IPC: C07K16/28
Filed: 2020-11-19
Abstract: Provided are methods of treating cancer or increasing, enhancing, or stimulating an immune response with non-competitive, agonist anti-OX40 antibodies and antigen-binding fragments thereof that bind to human OX40 (ACT35, CD134, or TNFRSF4), in combination with an anti-PD1 or with an anti-PDL1 antibody.
Patent MX-2022007488-A (MX)
Title: Selective cdk4/6 inhibitor cancer therapeutics.
Inventor: LISANTI MICHAEL P
IPC: A61P35/00
Filed: 2020-12-15
Abstract: The disclosure describes selective and potent CDK 4/6 inhibitors that show advantageous inhibition of cancer growth, even at low concentrations. A class of the CDK 4/6 inhibitors relates to substituted pyridopyrimidines compounds having a fatty acid moiety, and are namely derivatives of Palbociclib of general formula [2A], wherein R<sup>1</sup> is hydrogen, aryl, alkyl, alkoxy, cycloalkyl, or heterocyclyl; R<sup>2</sup> is hydrogen, halogen, alkyl, acyl, cycloalkyl, alkoxy, alkoxy alkyl, haloalkyl, hydroxy alkyl, alkenyl, alkynyl, nitrile, or nitro; R<sup>3</sup> is hydrogen, halogen, alkyl, haloalkyl, hydroxy alkyl, or cycloalkyl; and n is an integer from 9 to 20. These compounds may be used as pharmaceutical compounds for anti-cancer therapies, and are useful for the treatment, prevention and/or amelioration of cancer.
Patent MX-2022007797-A (MX)
Title: Biasing device for spinal device.
Inventor: ARNIN URI
IPC: A61B17/70
Filed: 2020-12-20
Abstract: A spinal device includes a rod which has a first end disposed in a housing and a second end which protrudes out of the housing through an aperture and which is movable to protrude more out of the housing or less out of the housing. A biasing device, mounted on the rod, includes a series of connected at-least partial coils. A first end of the biasing device is arranged to abut against the housing and a second end of the biasing device, opposite to the first end, is affixed to the rod.
Patent MX-2022009117-A (MX)
Title: Method for playing videos and electronic device.
Inventor: WU XIN
IPC: H04N21/44
Filed: 2022-07-22
Abstract: A method for playing videos can include: playing a first video; displaying a video viewing portal on a playback interface of the first video, wherein the video viewing portal is configured for viewing of videos related to the first video; switching, in response to no trigger operation on the video viewing portal being detected within a first reference duration, the video viewing portal to a float window corresponding to a second video related to the first video; and playing the second video in response to a trigger operation on the float window.
Patent MX-2022009847-A (MX)
Title: Glass redox control in submerged combustion melting.
Inventor: VEMPATI UDAYA
IPC: C03B5/235
Filed: 2021-02-11
Abstract: A method of producing glass using submerged combustion melting is disclosed. The method includes introducing a vitrifiable feed material (30) into a glass melt (22) contained within a submerged combustion melter (10). The glass melt contained in the melter has a redox ratio defined as a ratio of Fe2+ to total iron in the glass melt. The method further includes combusting a combustible gas mixture (G) supplied to each of the submerged burners (62) to produce combustion products (68), and discharging the combustion products directly into the glass melt. Still further, the method includes adjusting the redox ratio of the glass melt by controlling one or more operating conditions of the submerged combustion melter selected from (1) an oxygen-to- fuel ratio of the combustible gas mixture supplied to each of the submerged burners, (2) a residence time of the glass melt, and (3) a gas flux through the glass melt.
Patent MX-2022012372-A (MX)
Title: Hemodialysis systems and methods.
Inventor: GRANT KEVIN L
IPC: A61M1/14
Filed: 2009-08-27
Abstract: A hemodialysis system, comprising: a blood flow path; a first cassette defining an inner dialysate fluid path; a dialyzer in fluid communication with the blood flow path and the inner dialysate fluid path; a second cassette defining an outer dialysate fluid path; and a filter fluidly connecting the first cassette to the second cassette.
Patent MX-2022015788-A (MX)
Title: Methods and compositions for editing the b2m locus in b cells.
Inventor: RAWLINGS DAVID J
IPC: A61K35/17
Filed: 2021-06-30
Abstract: Some embodiments of the methods and compositions provided herein include preparing modified B cells. In some embodiments, an endogenous beta-2 microglobulin (B2M) gene in a B cell is modified. Some embodiments relate to increasing the resistance of modified B cells to killing by allogeneic immune cells. In some embodiments, the endogenous B2M gene is inactivated increasing the resistance of the modified B cell to killing by allogeneic immune cells. In some embodiments, a replacement MHC-I is inserted into an inactivated endogenous B2M gene increasing the resistance of the modified B cell to killing by allogeneic immune cells. Some embodiments include enriching for successfully modified cells.